Evaluation of the correlation between genetic damage and occupational chromate exposure through BNMN frequencies

Journal of Occupational and Environmental Medicine

Volumn 54, Issue 2, 2012, Pages 166-170

  Liu, Xiaohua ^a   Song, Yanshuang ^a   Wang, Li ^b,c   Li, Yuhui ^e   Zhang, Ji ^d   Ma, Yanhui ^d   Wang, Yun ^e   Ma, Wenjun ^a   Yan, Lei ^a   Jia, Guang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BAOTOU MEDICAL COLLEGE   (China)

^c Hospital of Inner Mongolia North Heavy Industries Group   (China)

^d Jinan Municipal Center for Disease Control and Prevention   (China)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIC ACID;

ADULT; AIR; ARTICLE; BINUCLEATED CELL WITH MICRONUCLEUS FREQUENCY; BLOOD; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HUMAN; HUMAN CELL; MALE; OCCUPATIONAL EXPOSURE; PERIPHERAL LYMPHOCYTE; PROCEDURES CONCERNING CELLS; URINE; WORKER;

ADULT; AIR POLLUTANTS; AIR POLLUTANTS, OCCUPATIONAL; BIOLOGICAL MARKERS; CHROMATES; CHROMIUM; DNA DAMAGE; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MIDDLE AGED; OCCUPATIONAL EXPOSURE;

EID: 84857367667     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31823d86b4     Document Type: Article

References (42)

1. Gambelunghe A, Piccinini R, Ambrogi M, et al. Primary DNA damage in chrome-plating workers. Toxicology. 2003;188:187-195. (Pubitemid 36603327)
2. Andersson MA, Petersson Grawé KV, Karlsson OM, Abramsson-Zetterberg LAG, Hellman BE. Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells in vivo and in vitro. Food Chem Toxicol. 2007;45:1097-1106. (Pubitemid 46590551)
3. Cohen MD, Kargacin B, Klein CB, Costa M. Mechanisms of chromium carcinogenicity and toxicity. Crit Rev Toxicol. 1993;23:255-281. (Pubitemid 23274470)
4. Ciesĺak-Golonka M. Toxic and mutagenic effects of chromium(VI): a review. Polyhedron. 1995;15:3667-3689.
5. Hininger I, Benaraba R, Osman M, Faure H, Roussel AM, Anderson RA. Safety of trivalent chromium complexes: No evidence for DNA damage in human HaCaT keratinocytes, Free Radic Biol Med. 2007;42:1759-1765. (Pubitemid 46778805)
6. Collins BJ, Stout MD, Levin KE, et al. Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice. Toxicol Sci. 2010;118:368-379.
7. O'Brien TJ, Ceryak S, Patierno SR. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res. 2003;533:3-36. (Pubitemid 37487859)
8. Shi X, Chiu A, Chen CT, Halliwell B, Castranova V, Vallyathan V. Reduction of chromium(VI) and its relationship to carcinogenesis. J Toxicol Environ Health. 1999;2:87-104. (Pubitemid 30054867)
9. Kasprzak KS. Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest. 1995;13:411-430.
10. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology. 2002;180: 5-22. (Pubitemid 35248089)
11. Nickens KP, Patierno SR, Ceryak S. Chromium genotoxicity: a double-edged sword. Chem Biol Interact. 2010;188:276-288.
12. Van Wijngaarden E, Mundt KA, Luippold RS. Evaluation of the exposureresponse relationship of lung cancer mortality and occupational exposure to hexavalent chromium based on published epidemiological data. Nonlinearity Biol Toxicol Med. 2004;2:27-34.
13. Michaels D, lurie P, Monforton C. Lung cancer mortality in the German chromate industry, 1958 to 1998. J Occup Environ Med. 2006;48:426-433.
14. Wang TC, Jia G, Zhang J, et al. Renal impairment caused by chronic occupational chromate exposure. Int Arch Occup Environ Health. 2011;60:67-70.
15. Lock EA. Sensitive and early markers of renal injury: where are we and what is the way forward? Toxicol Sci. 2010;116:1-4.
16. Emil R, Miroslav C? , Jaroslav C, Ladislava S. Hexavalent chromium disrupts the actin cytoskeleton and induces mitochondria-dependent apoptosis in human dermal fibroblasts. Toxicol In Vitro. 2005;19:713-723.
17. Emil R, Ladislava S, Vera K,Miroslav ? C. Hexavalent chromium induces DNA damage and activates DNA damage-response pathway in human skin cells. Toxicol Lett. 2008;180:32-246.
18. Fleury C, Petit A, Mwale F, et al. Effect of cobalt and chromium ions on human MG-63 osteoblasts in vitro: morphology, cytotoxicity, and oxidative stress. Biomaterials. 2006;27:3351-3360.
19. Mazzer PA, Maurmann L, Bose RN. Mechanisms of DNA damage and insight into mutations by chromium(VI) in the presence of glutathione. J Inorg Biochem. 2007;101:44-55. (Pubitemid 44879607)
20. Xu J, Manning FC, O'Brien TJ, Ceryak S, Patierno SR. Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cellfree systems: Relationship to RNA polymerase arrest. Mol Cell Biochem. 2004;255:151-160. (Pubitemid 38159775)
21. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Chromium, Nickel and Welding. Lyon, France: IARC. 49;1990:1-648.
22. Wang HJ, Du XM, Wang M, et al. Using ion-pair reversed-phase HPLC ICP-MS to simultaneously determine Cr(III) and Cr(VI) in urine of chromate workers. Talanta. 2010;81:1856-1860.
23. Annekatrin L, Paolo T, Anatoly Z, et al. Occupational exposure to Cr(VI): comparison between chromium levels in lymphocytes, erythrocytes, and urine. Int Arch Occup Environ Health. 1996;69:39-44.
24. Qu QS, Li XM, An FY, et al. Cr(VI) exposure and biomarkers: Cr in erythrocytes in relation to exposure and polymorphisms of genes encoding anion transport proteins. Biomarkers. 2008;13:467-477.
25. KuoHW, Chang SF,Wu KY,Wu FY. Chromium (VI) induced oxidative damage to DNA: increase of urinary 8-hydroxydeoxyguanosine concentrations (8-OHdG) among electroplating workers. Occup Environ Med. 2003;60:590-594. (Pubitemid 36976405)
26. Li GR, Ma YH, Zhang J. A study of urinary 8-hydroxydeoxyguanosine (8-OHdG) as a biomarker for workers exposed to soluble chromate. Prev Med Trib. 2008;14:97-99.
27. Costa M, Zhitkovich A, Tonolo P. Monitoring human lymphocytic DNAprotein cross-links as biomarkers of biologically active doses of chromate. Envrion Health Perspect.1996;104:917-919. (Pubitemid 26402330)
28. Flores A, Perez JM. Cytotoxicity, apoptosis, and in vitro DNA damage induced by potassium chromate. Toxicol Appl Pharmacol. 1999;161: 75-81.
29. Werfel U, Langen V, Eickhoff I, et al. Elevated DNA single-strand breakage frequencies in lymphocytes of welders exposed to chromium and nickel. Carcinogenesis. 1998;19:413-418. (Pubitemid 28375442)
30. Fenech M. Cytokinesis-blockmicronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res. 2006;600:58-66.
31. Fenech M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov. 2002;7:1128-1137. (Pubitemid 35346420)
32. El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD, Spitz MR. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res. 2006;66:6449-6456.
33. Bonassi S, Znaor A, Ceppi M, et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis. 2007;28:625-631. (Pubitemid 46523357)
34. Vaglenov A, Nosko M, Georgieva R, Carbonell E, Creus A, Marcos R. Genotoxicity and radioresistance in electroplating worker exposed to chromium. Mutat Res. 1999;446:23-34. (Pubitemid 29516658)
35. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Portocol. 2007;5:1084-1104. (Pubitemid 46901289)
36. Zak J. Hex chrome PEL Guidance: An overview of the employee exposure monitoring required for compliance with the new OSHA standard. Metal Finishing. 2006;104:41-43. (Pubitemid 44096911)
37. Fenech M. The in vitro micronucleus technique. Mutat Res. 2000;455: 81-95.
38. James DT, Ray JP. Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment. Mutat Res. 1996;365: 147-159.
39. Fenech M. Cytokinesis-block micronucleus techniques: a detailed description of themethod and its application to genotoxicity studies in human populations. Mutat Res. 1993;161:193-198.
40. Thompson CM, Haws LC, Harris MA, Gatto NM, Proctor DM. Application of the U.S. EPA mode of action framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium. Toxicol Sci. 2011;119:20-40.
41. Bonassi S, Fenech M, Lando C, et al. HUman MicroNucleus Project: International database Comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen. 2001;37:31-45.
42. Frouin H, Fortier M, Fournier M. Toxic effects of various pollutants in 11B7501 lymphoma B cell line from harbour seal (Phoca vitulina). Toxicology. 2010;270:66-76.